The Indian pharmaceutical industry has been granted approval to produce peptide diabetes drugs under the Production Linked Incentive (PLI) scheme. This move will not only boost the production of essential medications for diabetes patients but also create new job opportunities in the sector. The Pharma department is hopeful that this initiative will help make these life-saving drugs more accessible and affordable for those in need.
Source link
Google announces new 'AI Ultra' subscription plan: Price, benefits, other details
Google announced its premium AI subscription plan, Google AI Ultra, at I/O 2025 on May 20, 2025, priced at $249.99 per month, targeting filmmakers and creative professionals with extensive AI capabilities and a 50% discount for the first three months. Subscribers will enjoy enhanced access to the Gemini app, AI filmmaking tools, 30TB of storage, and an individual YouTube Premium subscription. Additionally, the existing AI Premium plan has been renamed to AI Pro, offering new...
Read more